The Gide x Regimbeau – Patent Litigation team took part in one of the very first hearings on the merits before the UPC Court of Appeal
The Gide x Regimbeau – Patent Litigation team took part in one of the very first hearings on the merits before the UPC Court of Appeal, held in Luxembourg on 4–5 September. On this occasion, the team represented Meril Italy in revocation proceedings against a first European patent held by Edwards Lifesciences.
One week later, the team appeared again before the UPC Central Division in Paris, this time acting for several companies of the Meril group in litigation relating to the validity and alleged infringement of a second European patent, also held by Edwards Lifesciences.
Team
Before the Court of Appeal (Luxembourg)
Anne Seibel, Aurélien Grimberg, Julien Guesnier (Regimbeau); Emmanuel Larere, Raphaëlle Dequiré-Portier, Luca Chevallier, Ludivine Messirel, Carole-Anne Bauer (Gide); Andreas von Falck and Alexander Klicznik (Hogan Lovells); Jonathan Stafford and Gregory Carty-Hornsby (Marks & Clerk).
Before the Central Division (Paris)
Anne Seibel, Aurélien Grimberg, Julien Guesnier (Regimbeau); Jean-Hyacinthe de Mitry, Emmanuel Larere, Marie-Ange Pozzo di Borgo, Célia Révy, Emmanuel Baux-Hendrix (Gide); Jonathan Stafford and Gregory Carty-Hornsby (Marks & Clerk).
This case is part of the closely watched litigation before the UPC, specifically in the field of heart-valve technologies, and was recently highlighted by JUVE Patent in the article “Paris central division upholds Edwards patent in heart-valve saga” (Konstanze Richter, 24 October 2025).
